Site icon Market Globalist

Why RedHill Biopharma (RDHL) Stock Is Falling 11% Today?

IMTE Stock

IMTE Stock

The biopharmaceuticals firm RedHill Biopharma Ltd. (RDHL) is facing a -11.27% decline in its share price during pre-market trading today following the announcement of an offering of $10 million of its American Depositary Shares (ADS).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.  

What happened?

RedHill Biopharma is involved in the biopharmaceuticals segment focused mostly on infectious diseases and gastrointestinal disorders.

In addition to the gastrointestinal drugs Movantik and Talicia, Redhill offers Aemcolo for the treatment of travelers’ diarrhea in adults.

Among RedHill’s clinical late-stage development programs are:

On Monday, RedHill Biopharma announced that it has signed an underwriting agreement with H.C. Wainwright & Co., LLC.

Exit mobile version